Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study.

Ryuta UrakawaEmiko Tanaka IsomuraKazuhide MatsunagaKazumi KubotaMiho Ike

Published in: BMC infectious diseases (2022)

Adverse reactions to BNT162b2 were found to be more frequent and more intense in females and younger people in Japan, especially after the second vaccination.

Keyphrases

coronavirus disease
sars cov
healthcare
physical activity
risk factors
binding protein